This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Measurement of Pain and Medication Effect in a Study of Duloxetine

Jay M. Griffith, MD; Joseph P. Hasley, MA; and Daniel G. Severn, DO, MPA

Published: June 30, 2008

Article Abstract

Letter to the Editor

Sir: We would like to comment on the November 2007 articleby Brecht et al. that addressed the efficacy and safety ofduloxetine in treating pain in patients experiencing major depressivedisorder. We concur with the authors that co-occurringpain and depression is a clinical issue of utmost importance, onethat has only recently begun to gain a level of attention commensuratewith its clinical impact. However, we believe that anumber of issues potentially limit this investigation’s applicabilityto the clinical setting.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 69

Quick Links: Neurologic and Neurocognitive , Neurology

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Meta-Analysis

Comparative Effects of 11 Antipsychotics on Weight Gain and Metabolic Function in Patients With Acute Schizophrenia: A Dose-Response Meta-Analysis

Although effects on weight gain have been explored for several antipsychotics, the role of dose in producing...

Read More...